Virus Diseases
111
0
3
89
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
31 trials with published results (28%)
Research Maturity
89 completed trials (80% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.5%
5 terminated out of 111 trials
94.7%
+8.1% vs benchmark
23%
25 trials in Phase 3/4
35%
31 of 89 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 89 completed trials
Clinical Trials (111)
Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vaccines in Adults
Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)
A Study of the Safety of and Immune Response to Varying Doses of a Vaccine Against COVID-19 in Healthy Adults
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed
Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD
Hypertonic Saline Nasal Irrigation and Gargling in Suspected or Confirmed COVID-19 (ELVIS COVID-19)
Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma
Congenital Heart Anomaly Risk in Maternal Enteroviral Infection and Diabetes
Evaluating the Human Immune Response to the JYNNEOS Vaccine
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
Analysis of Single Respiratory Viral Infections Versus Co-infections: Prevalence and ICU Needs in Hospitalized Adults
Ad26.ZEBOV, MVA-BN-Filo Vaccination in Children and Adults Previously Vaccinated With Control in the EBOVAC-Salone Study
Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men
Universal Anti-Viral Vaccine for Healthy Elderly Adults
Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and/or H5N6 Influenza Vaccine in Adults
LázBarát™ (FeverFriend™) Projekt: Attitude Toward Fever and Its Change in the Healthcare System
Cantharidin and Occlusion in Verruca Epithelium
Post-COVID-19 Monitoring in Routine Health Insurance Data
A Phase 3 Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.